nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of XPD Lys751Gln and XRCC1 T–77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
|
Liu, Li |
|
2011 |
73 |
1 |
p. 110-115 6 p. |
artikel |
2 |
Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer
|
Cho, Sukki |
|
2011 |
73 |
1 |
p. 25-31 7 p. |
artikel |
3 |
Contents
|
|
|
2011 |
73 |
1 |
p. vii-viii nvt p. |
artikel |
4 |
Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors
|
Brevet, Marie |
|
2011 |
73 |
1 |
p. 96-102 7 p. |
artikel |
5 |
Editorial Board
|
|
|
2011 |
73 |
1 |
p. v- 1 p. |
artikel |
6 |
IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation
|
Chen, Yuan |
|
2011 |
73 |
1 |
p. 38-44 7 p. |
artikel |
7 |
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA)
|
Banna, Giuseppe Luigi |
|
2011 |
73 |
1 |
p. 78-88 11 p. |
artikel |
8 |
New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy
|
Lee, Ho Yun |
|
2011 |
73 |
1 |
p. 63-69 7 p. |
artikel |
9 |
Optimal anatomic coverage for CT in staging lung cancer: Lessons from PET-CT correlation
|
Gross, Barry H. |
|
2011 |
73 |
1 |
p. 59-62 4 p. |
artikel |
10 |
Pleural epithelioid hemangioendothelioma in an elderly patient. A case report and review of the literature
|
Márquez-Medina, Diego |
|
2011 |
73 |
1 |
p. 116-119 4 p. |
artikel |
11 |
Positive urinary cytology in patients with lung cancer in the absence of obvious urine tract metastases
|
Voulgaris, E. |
|
2011 |
73 |
1 |
p. 51-58 8 p. |
artikel |
12 |
Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population
|
Ma, Hongxia |
|
2011 |
73 |
1 |
p. 32-37 6 p. |
artikel |
13 |
Prevalence and effectiveness of first-, second-, and third-line systemic therapy in a cohort of unselected patients with advanced non-small cell lung cancer
|
Zietemann, V. |
|
2011 |
73 |
1 |
p. 70-77 8 p. |
artikel |
14 |
Significance of microscopic invasion into hilar peribronchovascular soft tissue in resection specimens of primary non-small cell lung cancer
|
Sakai, Yasuhiro |
|
2011 |
73 |
1 |
p. 89-95 7 p. |
artikel |
15 |
The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma
|
Kozu, Yoshiki |
|
2011 |
73 |
1 |
p. 45-50 6 p. |
artikel |
16 |
Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer
|
Takeda, Masayuki |
|
2011 |
73 |
1 |
p. 103-109 7 p. |
artikel |
17 |
Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines
|
de Marinis, Filippo |
|
2011 |
73 |
1 |
p. 1-10 10 p. |
artikel |
18 |
Urinary isothiocyanate levels and lung cancer risk among non-smoking women: A prospective investigation
|
Fowke, Jay H. |
|
2011 |
73 |
1 |
p. 18-24 7 p. |
artikel |
19 |
Vaccines for the treatment of non-small cell lung cancer: Investigational approaches and clinical experience
|
Mellstedt, Håkan |
|
2011 |
73 |
1 |
p. 11-17 7 p. |
artikel |